Clinical Trial Services
Strategic, End-to-End Clinical Support for Novel Medical Devices
CardioMed partners with sponsors to design and execute clinical programs that are aligned with regulatory expectations and tailored to the complexities of Class II and Class III devices, including implantable and interventional technologies.
Comprehensive Clinical
Program Execution
- Clinical strategy aligned with IDE, PMA, 510(k), and global pathways
- Study design, endpoint selection, and statistical considerations
- Full protocol development and study planning
- CRO and vendor identification, qualification, and due diligence
- RFP support, bid evaluation, and contracting guidance
- Ongoing vendor oversight to ensure quality and timelines
- Clinical protocols and amendments
- Informed consent forms (ICFs)
- Adverse event narratives and clinical documentation
- Clinical Evaluation Reports (CERs)
- Literature review, data analysis, and critical appraisal
- Evidence strategy to support regulatory submissions
- End-to-end clinical project management (U.S. and OUS)
- Site and vendor coordination
- Timeline, risk, and milestone management
- Clinical site audits and GCP compliance assessments
- Mock audits and inspection readiness (FDA and global authorities)
Regulatory Intelligence
at Every Stage
CardioMed's senior consultants bring deep FDA experience and device-specific expertise to every engagement. We operate as an extension of your team — aligning clinical execution with regulatory strategy from day one.
Whether navigating IDE submissions, designing pivotal trials, or preparing for FDA inspection, our approach is built on proactive risk management, meticulous documentation, and a track record with complex, high-risk device programs.
Trusted Networks
Connected to the Right Partners for Every Program
CardioMed maintains a network of trusted CROs and specialized partners supporting clinical execution, data management, and biostatistics. We connect clients with high-quality providers tailored to their program needs, ensuring efficient and reliable study execution.
The CardioMed Difference
Regulatory alignment built on firsthand knowledge of FDA expectations, IDE processes, and device approval pathways.
Specialized experience with implantable, interventional, and Class III technologies that demand precision and rigor.
No junior handoffs. Your program is led by seasoned clinical and regulatory professionals from start to finish.
Seamless alignment of clinical and regulatory strategy — reducing gaps, accelerating timelines, and protecting your investment.
Ready to Advance Your Clinical Program?
Let's discuss your device, your timeline, and how CardioMed can deliver the strategic support your program demands.
Schedule a Consultation